On ECHEMI
Home > Drugs > Meisoindigo Registered Holders
Meisoindigo structure

Meisoindigo structure

Meisoindigo

Meisoindigo(Natura-α; N-Methylisoindigotin; Dian III), a derivative of Indigo naturalis, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).IC50 value:Target: apoptosis inducerin vitro: Meisoindigo inhibited the growth of leukemic cells by inducing marked apoptosis and moderate cell-cycle arrest at the G(0)/G(1) phase. It down-regulated anti-apoptotic Bcl-2, and up-regulated pro-apoptotic Bak and Bax and cell-cycle related proteins, p21and p27. Furthermore

Find 1 Related Holders

Beijing Xiehe Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    1981-04-04
  • Country:

    China China
  • Address:

    Building 7, No. 37 Yongwang Road, Daxing Biomedicine Industry Base, Zhongguancun Science Park, Daxing District, Beijing
  • Tax NO.:

    91110115101618619W
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Recommended Suppliers of Meisoindigo
View 14 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.